Comparative Trial of Furosemide-Spironolactone Combination and Furosemide-Metolazone Combination in Treating Refractory Edema in Nephrotic Syndrome Patients
DOI:
https://doi.org/10.37506/ajvea295Keywords:
Nephrotic syndrome, Edema, Furosemide, Spironolactone, MetolazoneAbstract
Introduction: Nephrotic syndrome is defined as the presence of nephrotic range proteinuria, hypercholesterolemia, and generalized edema. Proteinuria that is more than 85% albumin is selective proteinuria. Albumin has (-ve) charge, and it is loss of glomerular membrane (-ve) charges could be significant in causing albuminuria.
Objective: Comparison of Furosemide-Spironolactone Combination and Furosemide-Metolazone Combination in Treating Refractory Edema in Nephrotic Syndrome Patients.
Materials and methods: This was a cross-sectional study design of six month from December 2023 to May2024.
Results: The mean Age of the patients enrolled for the study with the minimum age being 1 year and maximum age being 14 years and the mean age was 5.6 years. It shows that weight loss at day 4 and 5 was significantly higher in group B as compared to group A.
Conclusions: Group B patients having lower mean abdominal girth as compared to group A. Mean Serum electrolyte values like S.Na+, S.K+, S.Ca+ of both the groups were compared and found to be similar thus highlighting that both the combinations had similar effects in the patients with respect to electrolyte abnormalities.
References
Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I et al. Steroid sensitive nephrotic syndrome: revised guidelines. Asian Journal of Pediatric Nephrology. 2021 Jul 1;4(2):48-66.
Patil RN, Bendale AG. A study of clinical profile and associated factors of nephrotic syndrome in children at tertiary health care center. Int JPediatr. 2017;2(1):5-7.
Ipparthy S, Tanneru S, Thomas SRJ, Thanda P.Clinical and demographic profile of nephrotic syndrome in a rural tertiary care center. Int J ContempPediatr2023;10:349-52.
McCloskey O, Maxwell AP. Diagnosis and management of nephrotic syndrome. Practitioner. 2017 Feb;261(1801):11-5.
Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003; 362: 629-39.
Wu MY, Chen CS, Yiang GT, Cheng PW, Chen YL, Chiu HC, et al. The Emerging Role of Pathogenesis of IgA nephropathy. J Clin. Med. 2018 Aug 20. 7(8):716-21.
Humphreys MH. Mechanisms and management of nephrotic edema. Kidney Int 1994; 45: 266–281
Palmer BF, Alpern RJ. Pathogenesis of edema formation in the nephrotic syndrome. Kidney Int Suppl 1997; 59: S21–S27.
Vande Walle J, Donckerwolcke R, Boer P, van Isselt HW, Koomans HA, Joles JA. Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney Int 1996; 49: 1471–1477.
Dorhout Mees EJ, Geers AB, Koomans HA. Blood volume and sodium retention in the nephrotic syndrome: a controversial pathophysiological concept. Nephron 1984; 36: 201–211.
Koomans HA, Geers AB, vdMeiracker AH, Roos JC, Boer P, Dorhout Mees EJ. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome. Am J Nephrol 1984; 4: 227–234.
Arnold WC. Efficacy of metolazone and furosemide in children with furosemide-resistant edema. Pediatrics. 1984; 74:872–875
Paton RR, Kane RE. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharmacol. 1977; 17:243–251.
Ghose RR, Gupta SK. Synergistic action of metolazone with ‘loop’ diuretics. BMJ. 1981;282:1432–1433.
Marone C, Muggli F, Lahn W, Frey FJ: Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man. European Journal of Clinical Investigation (1985) 15,253-257.
Oimomi M, Takase S, Saeki S. Combination diuretic therapy for severe refractory nephrotic syndrome. The Lancet 1990; 336:1004-1005.
Sica DA, and Gehr TWB . Diuretic Combinations in Refractory Oedema States. Clin. Pharmacokinet. 1996 Mar; 30 (3): 229-249.
Salahudin M, Shah H, Jan MU, Altaf A. Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. J Pak Med Assoc. 2019 Dec;69(12):1794-1799.
Cachero SD, Lofland G, Springate JE, Feld LG. Combination of metolazone and furosemide in the treatment of edema in the first month of life. Child Nephrology and Urology. 1990 ;10(3):161-163.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Gaurav Arya, Shashi Vinod, Akshay Shukla, Seema Barman, Santosh Kumar Barman, Navin Kumar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.